Dedicated to supporting the growth of promising early-stage life science startups through strategic investment, mentorship and hands-on industry expertise.

Life-science consultancy specialised on Business Development, Licensing, Partnering and Collaborations.Helping organisations build, maintain and leverage strategic alliances and partnerships by providing tailored training, expert advice, guidance and support through all phases of the partnering process.

Horizon Discovery, a PERKIN ELMER company, is a global leader in the application of gene editing and gene modulation technologies for therapeutic use.Driving commercial out-licensing and partnering activities for Horizon’s proprietary base editing technologies to pharmaceutical and biotechnology partners.

Sirion Biotech, a PERKIN ELMER company, is a world leader in viral vector-based gene delivery technologies for gene and cell therapy and vaccine development.Supporting Sirion's BD&L transactions and deal negotiations with biopharma partners for novel Cell & Gene therapies, therapeutic viral vectors and proprietary technology platforms based on lenti-, adeno-, and adeno-associated viruses.

Orchard Therapeutics is a leading global fully integrated commercial-stage company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies.Managing Orchard’s new business development initiatives, dealmaking activity and all aspects of strategic partnering with external, academic and industrial collaborators.

Vectura is a provider of innovative inhaled drug delivery services that enable partners to bring their medicines to patients. With differentiated proprietary technology and pharmaceutical development expertise, Vectura is one of the few companies globally with the device, formulation and development capabilities to deliver a broad range of complex inhaled therapies.Driving strategic partnering activities and BD&L projects, including in/out-licensing, feasibility studies, and R&D collaborations with biopharma partners.

Co-founding and running consulting firm specialised in business development and deal-making for the pharmaceutical industry in Latin America.Helping small and mid-sized pharmaceutical companies in Latin America create new business and achieve sustainable external growth through strategic partnerships, collaborations and licensing.

Management and coordination of all local/regional BD&L projects of the Pierre Fabre affiliates in Germany and Latin America.

Promoted and advised on the company's dermatology brands and generics to selected dermatologists and general practitioners.

Responsible for all aspects of primary and secondary market research and related activities for the company’s product portfolio of RX drugs and OTC brands.Core member of the New Business Development team and actively involved in opportunity scouting and evaluating the market potential of new business opportunities, in- licensing candidates and product accquisitions.